Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gene Massey

Orthopaedic Surgery of the Spine Myrtle Beach, SC Medical Doctor

NPI 1881727139 CMS profile 445513

210 Village Center Blvd., Suite 200, Myrtle Beach, SC 29579

Open in the dashboard

General payments

$1,234,324

353 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gene Massey of Myrtle Beach, SC is reported in the CMS Open Payments database as having received $1,234,324 across 353 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $335,234 19
2024 General $305,826 38
2023 General $161,025 55
2022 General $111,709 50
2021 General $163,006 87
2020 General $112,070 61
2019 General $45,455 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gene Massey
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Gene Massey were reported at $335,234. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Gene Massey Orthopaedic Surgery of the Spine median Middle half National median
2019 $45,455 $2,106 $337–$18,608 $163
2020 $112,070 $1,213 $156–$15,082 $114
2021 $163,006 $1,834 $271–$15,617 $132
2022 $111,709 $2,015 $320–$17,036 $149
2023 $161,025 $1,925 $336–$14,599 $160
2024 $305,826 $2,110 $341–$12,483 $164
2025 $335,234 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $1,145,388 245 payments
  2. DeGen Medical, Inc. $70,230 44 payments
  3. Medtronic USA, Inc. $18,082 32 payments
  4. Abbott Laboratories $217 5 payments
  5. Boston Scientific Corporation $126 14 payments
  6. Stryker Corporation $63 2 payments
  7. Innovation Technologies Inc $45 1 payment
  8. NuVasive, Inc. $40 2 payments
  9. Medtronic, Inc. $31 2 payments
  10. Cerapedics, Inc. $25 1 payment
  11. Other $76 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $613,495 70 payments
  2. Royalty or License $526,510 33 payments
  3. Travel and Lodging $86,369 135 payments
  4. Food and Beverage $7,725 110 payments
  5. Entertainment $225 5 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $623,106 120 payments
  2. SafeOp $57,683 12 payments
  3. LTP $48,250 9 payments
  4. AMP $41,750 2 payments
  5. E3 MIS Lumbar System $25,155 8 payments
  6. E3 Lumbar System $18,080 6 payments
  7. IMPULSE $13,413 1 payment
  8. E3 Lumbar Mis $11,282 5 payments
  9. CLYDESDALE $10,444 8 payments
  10. Solus ALIF $8,417 4 payments
  11. Other $33,531 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

615

Median for Orthopedic Surgery: 203

Drug cost

$4,577

Median for Orthopedic Surgery: $1,433

Branded share of claims

12.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 168 $1,689
Prednisone Generic 127 $1,166
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 53 $495
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $264
Celecoxib Generic 20 $240
Cyclobenzaprine Hcl Generic 49 $197
Tizanidine Hcl Generic 35 $155
Naproxen Generic 16 $101
Oxycodone Hcl Generic 25 $95
Tramadol Hcl Generic 34 $80

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$444,357

Of which drugs: $538

Medicare patients

1,013

Average age 74

Services billed

3,770

566 women, 447 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 28%
Ischemic heart disease 24%
Chronic kidney disease 21%
Depression 21%
Atrial fibrillation 17%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 22 100 $538

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

353 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record